ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Solvonis Therapeutics Plc

Solvonis Therapeutics Plc is an active company incorporated on 18 May 2017 with the registered office located in London, Greater London. Solvonis Therapeutics Plc was registered 8 years ago.
Status
Active
Active since incorporation
Company No
10776788
Public limited company
Age
8 years
Incorporated 18 May 2017
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 17 May 2025 (3 months ago)
Next confirmation dated 17 May 2026
Due by 31 May 2026 (8 months remaining)
Last change occurred 3 years ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 June 2026 (9 months remaining)
Contact
Address
Eccleston Yards
25 Eccleston Place
London
SW1W 9NF
United Kingdom
Same address for the past 4 years
Telephone
07795 430246
Email
Unreported
People
Officers
10
Shareholders
28
Controllers (PSC)
1
Secretary • Secretary
Director • None • Russian • Lives in Slovenia • Born in Apr 1957
Director • Cfo • British,israeli • Lives in UK • Born in Dec 1970
Director • Chair Person • American • Lives in United States • Born in Jun 1955
Director • Non-Executive Director • British • Lives in UK • Born in Jul 1955
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Graftbio Limited
Yifat Steuer and Nicholas Nelson are mutual people.
Active
Isabel Hospice Limited
Renata Crome is a mutual person.
Active
Capital Metals Plc
Orana Corporate LLP is a mutual person.
Active
Steuer Consulting Limited
Yifat Steuer is a mutual person.
Active
Wecap Plc
Orana Corporate LLP is a mutual person.
Active
Pten Research Foundation
Renata Crome is a mutual person.
Active
Critical Mineral Resources Plc
Orana Corporate LLP is a mutual person.
Active
Tasmania Vodka Ltd
Orana Corporate LLP is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2018–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£757K
Increased by £570K (+305%)
Turnover
Unreported
Decreased by £587K (-100%)
Employees
3
Decreased by 4 (-57%)
Total Assets
£3.2M
Increased by £737K (+30%)
Total Liabilities
-£119K
Decreased by £321K (-73%)
Net Assets
£3.08M
Increased by £1.06M (+52%)
Debt Ratio (%)
4%
Decreased by 14.13% (-79%)
Latest Activity
Confirmation Submitted
3 Months Ago on 27 May 2025
Group Accounts Submitted
4 Months Ago on 7 May 2025
Mrs Renata Crome Appointed
5 Months Ago on 11 Mar 2025
Orana Corporate Llp Appointed
7 Months Ago on 31 Jan 2025
Anthony Eastman Resigned
7 Months Ago on 31 Jan 2025
Mr Dennis Purcell Appointed
11 Months Ago on 26 Sep 2024
Yifat Steuer Resigned
1 Year Ago on 12 Aug 2024
Victor Bolduev Resigned
1 Year 1 Month Ago on 31 Jul 2024
Pavel Kobzev Resigned
1 Year 1 Month Ago on 15 Jul 2024
Confirmation Submitted
1 Year 3 Months Ago on 22 May 2024
Get Credit Report
Discover Solvonis Therapeutics Plc's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 24 July 2025
Submitted on 29 Jul 2025
Statement of capital following an allotment of shares on 10 July 2025
Submitted on 17 Jul 2025
Resolutions
Submitted on 4 Jul 2025
Confirmation statement made on 17 May 2025 with no updates
Submitted on 27 May 2025
Statement of capital following an allotment of shares on 27 May 2025
Submitted on 27 May 2025
Group of companies' accounts made up to 31 December 2024
Submitted on 7 May 2025
Resolutions
Submitted on 7 May 2025
Appointment of Mrs Renata Crome as a director on 11 March 2025
Submitted on 14 Mar 2025
Termination of appointment of Anthony Eastman as a secretary on 31 January 2025
Submitted on 5 Feb 2025
Appointment of Orana Corporate Llp as a secretary on 31 January 2025
Submitted on 5 Feb 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year